Related Experiment Video
Updated: Aug 6, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Multidrug-Resistant and Extensively Drug-Resistant Skeletal Tuberculosis: Systematic Review of Clinical Profile,
Anil Regmi1, Bishwa Bandhu Niraula2, Abdus Sami3
1Department of Orthopedics, Charak Memorial Hospital, Pokhara, Nepal.
Background:
Multidrug-resistant (MDR), pre-extensively drug-resistant (pre-XDR), and extensively drug-resistant (XDR) strains are associated with delayed diagnosis, protracted therapy, and increased morbidity. This article aims to systematically review the clinical spectrum, diagnostic strategies, drug resistance profiles, therapeutic regimens, surgical interventions, and outcomes of drug-resistant skeletal TB.
Methods:
A systematic search of PubMed, Scopus, and Embase up to September 2025 identified studies reporting ≥ 5 culture- or molecular-confirmed MDR, pre-XDR, or XDR skeletal TB cases. Data extraction included demographics, clinical features, diagnostics, drug susceptibility, treatment protocols, surgical management, and outcomes.
Results:
Twenty studies reported 1,242 drug-resistant cases: 1,032 spinal and 210 osteoarticular. MDR TB predominated, while pre-XDR/XDR cases ranged from 1.2 to 20%. Treatment success was 76-100% for MDR TB and 50-80% for pre-XDR/XDR TB; adverse events occurred in 33-55%. Recurrence and mortality were low (< 5-19%).
Conclusions:
MDR TB dominates drug-resistant skeletal TB, but pre-XDR/XDR cases demand complex management. Early molecular diagnosis, tailored multidrug regimens, and judicious surgical intervention are pivotal for optimal outcomes. A multidisciplinary strategy is essential to improve prognosis and limit long-term morbidity.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Clinical Significance of Antibiotic Resistance
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Mechanism of Antibiotic Resistance in MRSA